Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > News Release

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Aug 11, 2021 12:10pm

50 Views

Post# 33685125

RE:RE:RE:News Release

Why didn't they do one study with both BG and AVN and save millions of dollars and years in time? Mgmt seems to be flying by the seat of their pants. No strategic planning skills.

Ciao wrote: Perhaps they want a definitive study and evenutally could they be used together to improve heart health. There are some general articles on benefits of AV on heart health but I don't see any clinical studies.

https://honey-guide.com/2015/06/20/oat-avenanthramides/

User2020 wrote: Could it be inferred that the BG trials are going well as they are expanding the work to include avenanthramides? It has always been Gilles vision to combine the two products to reduce inflammation and cholesterol. This was one of the reasons they bought Juvente to combine beta-glucan and avenanthramides as a fomulation.